Non-Anticoagulant Heparins and Inhibition of Cancer

Publisher： Karger

E-ISSN： 1424-8840|36|3-4|195-203

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.36, Iss.3-4, 2009-01, pp. : 195-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Anticoagulant Effects of Heparin inCarcinoma Metastasis and Trousseau’s Syndrome

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 1, 2003-09 ,pp. : 64-66

Karger

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

The Role of EGFR-TK Inhibition in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 12, 2005-12 ,pp. : 619-620

Karger

Access to resources Recommend Favorite

Comparative Inhibition of LPS-Activated Human Monocyte-Induced Thrombin Generation by Unfractionated Heparin and Low Molecular Weight Heparins

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 6, 2000-06 ,pp. : 301-309

Karger

Access to resources Recommend Favorite

Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 175, Iss. 1, 2016-10 ,pp. : 123-132

John Wiley & Sons Inc

Access to resources Recommend Favorite